Skip to main content

Table 5 The correlation between clinical outcome and patient's characteristics

From: Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma

Baseline Factors Complete Remission
N (%)
Relapsed Disease
N (%)
Total P-value
Age at diagnosis     
< 30 43 (44.8) 19 (55.9) 62 0.266
≥ 30 53 (55.2) 15 (44.1) 68  
Gender     
Males 50 (52.1) 21 (61.8) 71 0.330
Females 46 (47.9) 13 (38.2) 59  
Histology     
NSa 46 (64.8) 16 (72.7) 62 0.490
MCb 25 (35.2) 6 (27.3) 31  
Stage     
Early stages (I &II) 41 (51.9) 20 (62.5) 61 0.309
Advanced stages (III & IV) 38 (48.1) 12 (37.5) 50  
Presence of B-symptoms     
Yes 54 (63.5) 19 (59.4) 73 0.679
No 31 (36.5) 13 (40.6) 44  
  1. aNodular sclerosis; bMixed cellularity.